ALB · NYSE
Albemarle Corporation
$93.89 +1.47 (+1.59%)
Company overview
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high-performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in steroid chemistry and vitamins, life sciences, the pharmaceutical industry, and other markets.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Exchange
- NYSE
- Market cap
- $11.1B
- Employees
- 8,300
- Headquarters
- Charlotte, NC
- Website
- albemarle.com
- CEO
- Jerry Kent Jr.
- Listed
- February 22, 1994
- P/E
- -27.61
- Dividend yield
- 1.38%
Company financials
- Revenue
- $5.5B
- Gross profit
- $1B
- Operating income
- $305M
- EBITDA
- $802M
- Net income
- -$233M
- EPS
- -$3.40
- Total assets
- $15.1B
- Total debt
- $1.9B
- Gross margin
- 18.53%
- Net margin
- -4.24%
- Earnings yield
- -3.62%
Showing FY 2025
ALB
1D
NYSE
O91.08H92.67L91.00C92.54-1.93 (-2.04%)Vol2.26M